James D’Olimpio

826 total citations
21 papers, 451 citations indexed

About

James D’Olimpio is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, James D’Olimpio has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in James D’Olimpio's work include Chronic Lymphocytic Leukemia Research (4 papers), Pain Management and Opioid Use (3 papers) and Diet and metabolism studies (3 papers). James D’Olimpio is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Pain Management and Opioid Use (3 papers) and Diet and metabolism studies (3 papers). James D’Olimpio collaborates with scholars based in United States, Canada and United Kingdom. James D’Olimpio's co-authors include Patricia May, Annabel Barber, Naji N. Abumrad, R. Doerr, Lola M. Reid, Delia F. Chiuten, Isabel Zvibel, Lynn B. Panton, Philip May and Steven Nissen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Surgery.

In The Last Decade

James D’Olimpio

18 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James D’Olimpio United States 7 237 136 121 61 58 21 451
Silvia Vichi Italy 8 148 0.6× 35 0.3× 122 1.0× 38 0.6× 99 1.7× 17 571
Marvin Petty United States 4 60 0.3× 72 0.5× 92 0.8× 29 0.5× 81 1.4× 4 591
Zbigniew Bartoszewicz Poland 15 173 0.7× 31 0.2× 97 0.8× 28 0.5× 123 2.1× 46 615
Shinobu Matsumoto Japan 16 123 0.5× 56 0.4× 129 1.1× 117 1.9× 142 2.4× 40 719
Hiroyasu Mori Japan 12 323 1.4× 98 0.7× 78 0.6× 119 2.0× 55 0.9× 37 638
Ryan N. Montalvo United States 13 155 0.7× 22 0.2× 153 1.3× 57 0.9× 103 1.8× 23 412
Qiulin Zhuang China 15 350 1.5× 27 0.2× 279 2.3× 108 1.8× 207 3.6× 27 768
Christin Spielhagen Germany 10 86 0.4× 26 0.2× 134 1.1× 81 1.3× 60 1.0× 20 558
Mimma Maggio Italy 11 290 1.2× 43 0.3× 126 1.0× 15 0.2× 81 1.4× 12 592
Noriyuki Kitagawa Japan 14 245 1.0× 41 0.3× 86 0.7× 75 1.2× 103 1.8× 74 622

Countries citing papers authored by James D’Olimpio

Since Specialization
Citations

This map shows the geographic impact of James D’Olimpio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James D’Olimpio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James D’Olimpio more than expected).

Fields of papers citing papers by James D’Olimpio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James D’Olimpio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James D’Olimpio. The network helps show where James D’Olimpio may publish in the future.

Co-authorship network of co-authors of James D’Olimpio

This figure shows the co-authorship network connecting the top 25 collaborators of James D’Olimpio. A scholar is included among the top collaborators of James D’Olimpio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James D’Olimpio. James D’Olimpio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Jain, Nitin, Catherine C. Coombs, James D’Olimpio, et al.. (2024). Preliminary Results from a Phase 1b Study of Non-Covalent Pan-Mutant BTK Inhibitor Docirbrutinib (AS-1763) in Patients with Previously Treated B-Cell Malignancies. Blood. 144(Supplement 1). 1866–1866.
5.
6.
Shadman, Mazyar, Ian W. Flinn, Edwin Kingsley, et al.. (2023). Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies. Blood. 142(Supplement 1). 3279–3279. 1 indexed citations
7.
D’Olimpio, James, et al.. (2013). Improving Quality of Life Through Pain Control. Clinical journal of oncology nursing. 17(2). 117–118. 2 indexed citations
8.
D’Olimpio, James, et al.. (2009). Phase II study of AVR118 in the management of cancer related anorexia/cachexia. Journal of Clinical Oncology. 27(15_suppl). e20631–e20631. 2 indexed citations
9.
D’Olimpio, James, et al.. (2008). Symptom Management in Geriatric Oncology: Practical Treatment Considerations and Current Challenges. Current Treatment Options in Oncology. 9(2-3). 204–214. 11 indexed citations
10.
D’Olimpio, James, et al.. (2007). Orexigenic and cytoprotective effects of a novel adenosine-enriched peptide nucleic acid compound: Implications for clinical application. Journal of Clinical Oncology. 25(18_suppl). 14154–14154. 2 indexed citations
11.
Pekmezaris, Renée, Arturo Zaballero, Gisele Wolf‐Klein, et al.. (2004). Predictors of Site of Death of End-of-Life Patients: The Importance of Specificity in Advance Directives. Journal of Palliative Medicine. 7(1). 9–17. 23 indexed citations
12.
D’Olimpio, James, et al.. (2004). Anti-cachectic effects of a novel peptide nucleic acid: Preliminary results of a phase 1/11 clinical trial. Journal of Clinical Oncology. 22(14_suppl). 8087–8087. 2 indexed citations
13.
Nissen, Steven, et al.. (2004). Supplementation with a combination of beta‐hydroxy‐beta‐methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. Journal of Parenteral and Enteral Nutrition. 28(2). 65–75. 63 indexed citations
14.
D’Olimpio, James, et al.. (2004). Anti-cachectic effects of a novel peptide nucleic acid: Preliminary results of a phase 1/11 clinical trial. Journal of Clinical Oncology. 22(14_suppl). 8087–8087. 1 indexed citations
15.
May, Patricia, et al.. (2002). Reversal of cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-methylbutyrate, arginine, and glutamine. The American Journal of Surgery. 183(4). 471–479. 242 indexed citations
16.
D’Olimpio, James. (2001). Contemporary Drug Therapy in Palliative Care: New Directions. Cancer Investigation. 19(4). 413–423. 6 indexed citations
17.
Doerr, R., Isabel Zvibel, Delia F. Chiuten, James D’Olimpio, & Lola M. Reid. (1989). Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases.. PubMed. 49(2). 384–92. 54 indexed citations
18.
D’Olimpio, James, Michael H. Miller, Carol Sheridan, et al.. (1987). A Comparative Trial of Moxalactam Plus Ticarcillin and Clavulanic Acid or Piperacillin as Empiric Antibiotic Therapy for Febrile Cancer Patients. The Journal of Clinical Pharmacology. 27(9). 673–677. 3 indexed citations
19.
Paietta, Elisabeth, et al.. (1985). Plasmacytoid blast crisis in B-cell chronic lymphocytic leukemia: Effect of estradiol on growth and differentiation in vitro. Leukemia Research. 9(1). 19–29. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Vichi Breakdown of academic impact, for papers by Marvin Petty Breakdown of academic impact, for papers by Zbigniew Bartoszewicz Breakdown of academic impact, for papers by Shinobu Matsumoto Breakdown of academic impact, for papers by Hiroyasu Mori Breakdown of academic impact, for papers by Ryan N. Montalvo Breakdown of academic impact, for papers by Qiulin Zhuang Breakdown of academic impact, for papers by Christin Spielhagen Breakdown of academic impact, for papers by Mimma Maggio Breakdown of academic impact, for papers by Noriyuki Kitagawa
Rankless by CCL
2026